Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Preventive Dendritic Cell Vaccination for Lynch Syndrome [Phase 1, Phase 2]

View source ↗

Summary

The document describes a Phase 1/2 clinical trial evaluating preventive dendritic cell vaccination for individuals with Lynch syndrome, which is currently not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dendritic cell vaccine

Snippet

Sponsor: Radboud University Medical Center | Conditions: Lynch Syndrome | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING